PlumX Metrics
Embed PlumX Metrics

Rates of complication for dilation and evacuation versus induction of labor in treatment of second trimester intrauterine fetal demise

European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN: 0301-2115, Vol: 277, Page: 16-20
2022
  • 3
    Citations
  • 0
    Usage
  • 14
    Captures
  • 3
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

‘I’m not afraid. Let’s do it’: the Arizona abortion clinic testing the limits of the state’s ban

The owner of the Camelback Family Planning is willing to take risks for patients that other doctors won’t, while staying within the bounds of the state’s abortion ban Gabrielle Goodrick’s day has barely begun and she’s already poring over a stack of legal documents. As the nurses and other doctors at her clinic start seeing the first of what will be upwards of 40 patients that day, the 59-year-old

Article Description

To evaluate clinical differences in the safety of dilation and evacuation (D&E) and induction of labor (IOL) for the treatment of intrauterine fetal demise (IUFD) between 14 and 24 weeks gestation. A retrospective chart review was conducted at a single institution comparing rates of major and minor complications between patients who undergo D&E and those that undergo IOL in the treatment of IUFD between 14 and 24 weeks gestation. Demographic and medical variables were stratified by management method and analyzed using chi-squared and t-tests where appropriate. Patients who underwent IOL were of a more advanced gestational age and more likely to be uninsured. Patients who underwent D&E were more likely to be privately insured. Hospital time for an IOL was significantly longer than for D&E. Composite rates of complication did not differ significantly between management groups. Patients treated with D&E were more likely to require uterine aspiration. D&E and IOL are equally safe methods for the management of IUFD between 14 and 24 weeks gestation. Both options should be made available to patients who experience this rare pregnancy outcome.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know